ATE224350T1 - Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäuren - Google Patents
Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäurenInfo
- Publication number
- ATE224350T1 ATE224350T1 AT97924788T AT97924788T ATE224350T1 AT E224350 T1 ATE224350 T1 AT E224350T1 AT 97924788 T AT97924788 T AT 97924788T AT 97924788 T AT97924788 T AT 97924788T AT E224350 T1 ATE224350 T1 AT E224350T1
- Authority
- AT
- Austria
- Prior art keywords
- oxobutanic
- aroylalkyl
- biaryl
- omega
- inhibition
- Prior art date
Links
- 102000005741 Metalloproteases Human genes 0.000 title 1
- 108010006035 Metalloproteases Proteins 0.000 title 1
- 239000002253 acid Substances 0.000 title 1
- 150000007513 acids Chemical class 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- 239000011159 matrix material Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
- C07C45/46—Friedel-Crafts reactions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/63—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/80—Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/76—Ketones containing a keto group bound to a six-membered aromatic ring
- C07C49/84—Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/76—Unsaturated compounds containing keto groups
- C07C59/88—Unsaturated compounds containing keto groups containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64502996A | 1996-05-15 | 1996-05-15 | |
| PCT/US1997/008608 WO1997043240A1 (en) | 1996-05-15 | 1997-05-12 | INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE224350T1 true ATE224350T1 (de) | 2002-10-15 |
Family
ID=24587374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97924788T ATE224350T1 (de) | 1996-05-15 | 1997-05-12 | Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäuren |
Country Status (22)
| Country | Link |
|---|---|
| EP (1) | EP0904260B1 (de) |
| JP (1) | JP3524556B2 (de) |
| CN (1) | CN1119313C (de) |
| AR (1) | AR007099A1 (de) |
| AT (1) | ATE224350T1 (de) |
| AU (1) | AU715877B2 (de) |
| BR (1) | BR9709078A (de) |
| CA (1) | CA2254750C (de) |
| CO (1) | CO5011071A1 (de) |
| DE (1) | DE69715619T2 (de) |
| ES (1) | ES2184092T3 (de) |
| HN (1) | HN1997000070A (de) |
| HR (1) | HRP970242A2 (de) |
| ID (1) | ID17938A (de) |
| PA (1) | PA8429601A1 (de) |
| PE (1) | PE66198A1 (de) |
| SV (1) | SV1997000038A (de) |
| TN (1) | TNSN97081A1 (de) |
| TW (1) | TW457231B (de) |
| WO (1) | WO1997043240A1 (de) |
| YU (1) | YU18397A (de) |
| ZA (1) | ZA974028B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO5011061A1 (es) | 1996-05-15 | 2001-02-28 | Bayer Corp | Inhibicion de las metaloprotesas de matriz por acidos biariloxobutiricos sustituidos y composiciones farmaceuticas que los contienen |
| TNSN97086A1 (fr) | 1996-05-15 | 2005-03-15 | Bayer Corp | La substitution des acides derivatives 4-albutyrique comme inhibiteurs de la matrice metalloprotease. |
| TNSN97082A1 (fr) | 1996-05-15 | 2005-03-15 | Bayer Corp | Inhibition des matrices metalloproteases par la substitution des composes phenetyles |
| CO4990925A1 (es) | 1996-05-15 | 2000-12-26 | Bayer Corp | Acidos oxibutiricos sustituidos como inhibidores de la metaloproteasa de matriz |
| US6288063B1 (en) | 1998-05-27 | 2001-09-11 | Bayer Corporation | Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors |
| EP1031349A1 (de) * | 1999-02-25 | 2000-08-30 | Bayer Aktiengesellschaft | Verwendung von substituierten 4-Biarylbuttersäuren und 5-Biarylpentansäuren zur Behandlung von zerebralen Krankheiten |
| US20170022171A1 (en) | 2014-04-03 | 2017-01-26 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentanecarboxylic acids and their use |
| US20170119776A1 (en) | 2014-04-03 | 2017-05-04 | Bayer Pharma Aktiengesellschaft | Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof |
| CA2944614A1 (en) | 2014-04-03 | 2015-10-08 | Bayer Pharma Aktiengesellschaft | 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratoy tract diseases |
| CN116687925B (zh) * | 2022-11-04 | 2024-10-22 | 中国科学院遗传与发育生物学研究所 | 一种侵蚀性蛋白酶抑制剂及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS243570B1 (en) * | 1984-08-31 | 1986-06-12 | Miroslav Kuchar | Omega-aryloxoalkane acids |
| GB9101468D0 (en) * | 1991-01-23 | 1991-03-06 | Ciba Geigy | Coating compositions |
| US5789434A (en) * | 1994-11-15 | 1998-08-04 | Bayer Corporation | Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors |
-
1997
- 1997-05-09 HR HR08/645,029A patent/HRP970242A2/xx not_active Application Discontinuation
- 1997-05-09 ZA ZA9704028A patent/ZA974028B/xx unknown
- 1997-05-09 TN TNTNSN97081A patent/TNSN97081A1/fr unknown
- 1997-05-09 CO CO97025187A patent/CO5011071A1/es unknown
- 1997-05-12 JP JP54119597A patent/JP3524556B2/ja not_active Expired - Fee Related
- 1997-05-12 PA PA19978429601A patent/PA8429601A1/es unknown
- 1997-05-12 PE PE1997000364A patent/PE66198A1/es not_active Application Discontinuation
- 1997-05-12 CN CN97196453A patent/CN1119313C/zh not_active Expired - Fee Related
- 1997-05-12 CA CA002254750A patent/CA2254750C/en not_active Expired - Fee Related
- 1997-05-12 HN HN1997000070A patent/HN1997000070A/es unknown
- 1997-05-12 DE DE69715619T patent/DE69715619T2/de not_active Expired - Fee Related
- 1997-05-12 AU AU30104/97A patent/AU715877B2/en not_active Ceased
- 1997-05-12 WO PCT/US1997/008608 patent/WO1997043240A1/en not_active Ceased
- 1997-05-12 EP EP97924788A patent/EP0904260B1/de not_active Expired - Lifetime
- 1997-05-12 SV SV1997000038A patent/SV1997000038A/es not_active Application Discontinuation
- 1997-05-12 TW TW086106287A patent/TW457231B/zh not_active IP Right Cessation
- 1997-05-12 AT AT97924788T patent/ATE224350T1/de not_active IP Right Cessation
- 1997-05-12 BR BR9709078A patent/BR9709078A/pt not_active IP Right Cessation
- 1997-05-12 ES ES97924788T patent/ES2184092T3/es not_active Expired - Lifetime
- 1997-05-12 YU YU18397A patent/YU18397A/sr unknown
- 1997-05-12 AR ARP970101979A patent/AR007099A1/es unknown
- 1997-05-14 ID IDP971608A patent/ID17938A/id unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR007099A1 (es) | 1999-10-13 |
| AU3010497A (en) | 1997-12-05 |
| DE69715619T2 (de) | 2003-01-16 |
| ZA974028B (en) | 1998-02-19 |
| CO5011071A1 (es) | 2001-02-28 |
| YU18397A (en) | 1999-11-22 |
| PE66198A1 (es) | 1998-10-23 |
| HN1997000070A (es) | 1997-09-08 |
| JP3524556B2 (ja) | 2004-05-10 |
| CA2254750A1 (en) | 1997-11-20 |
| ID17938A (id) | 1998-02-12 |
| ES2184092T3 (es) | 2003-04-01 |
| AU715877B2 (en) | 2000-02-10 |
| DE69715619D1 (de) | 2002-10-24 |
| TW457231B (en) | 2001-10-01 |
| CN1119313C (zh) | 2003-08-27 |
| WO1997043240A1 (en) | 1997-11-20 |
| HRP970242A2 (en) | 1998-04-30 |
| EP0904260B1 (de) | 2002-09-18 |
| SV1997000038A (es) | 1998-09-01 |
| EP0904260A1 (de) | 1999-03-31 |
| CN1234791A (zh) | 1999-11-10 |
| BR9709078A (pt) | 1999-08-03 |
| PA8429601A1 (es) | 2000-05-24 |
| TNSN97081A1 (fr) | 2005-03-15 |
| JP2001509783A (ja) | 2001-07-24 |
| CA2254750C (en) | 2003-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI965156A7 (fi) | Aryylisulfonamido-substituoidut hydroksaamihapot matriisimetalloprotei naasi-inhibiittoreina | |
| NO972307D0 (no) | Matriksmetallproteaseinhibitorer | |
| ATE217315T1 (de) | Matrix metalloprotease-inhibitoren auf basis von phosphinsäuren | |
| FI962800L (fi) | Fenyyliheterosyklisiä yhdisteitä COX-2 inhibiittoreina | |
| DE69621021D1 (de) | Inhibitoren der plättchenaggregation | |
| FI944033A7 (fi) | Uusia proteaaseja | |
| FI972062A7 (fi) | Substituoituja 4-biaryylivoi- tai 5-biaryylipentaanihappoja ja johdannaisia matriisimetalliproteaasi-inhibiittoreina | |
| FI933277A7 (fi) | Amiinidioli proteaasi-inhibiittorit | |
| FI961857A7 (fi) | Matriksin metalloproteaasien inhibiittorit | |
| BR9801606A (pt) | Acidos sulfonilaminocarboxílicos | |
| BR9405876A (pt) | Agregado hidráulico | |
| BR9612707A (pt) | Composiç o detergente compreendendo uma enzima pectinesterase | |
| NO20011966D0 (no) | Serin-protease-inhibitor | |
| ATE275123T1 (de) | Hemmung von matrixmetalloproteasen durch 2- substituierte-4-(4-substituiertphenyl)-4- oxobutansäuren | |
| FI960482A7 (fi) | Matriksin metalloproteaasien inhibiittorit | |
| EE200000241A (et) | 8-metoksükinoloonkarboksüülhapete valmistamismeetod | |
| ID17792A (id) | Penghambat penghambat metaloproreinase matriks | |
| ATE224350T1 (de) | Inhibition der matrix metalloproteasen durch 2- (omega-aroylalkyl)-4-biaryl-4-oxobutansäuren | |
| DE69736109D1 (de) | Differenzierungsinhibitor | |
| FI932427A7 (fi) | Syklopentaani- ja -penteeni-b-aminohapot | |
| EE9900180A (et) | Asendatud 4-bifenüül-4-hüdroksübutaanhappe derivaadid metalloproteaasimaatriksi inhibiitoritena | |
| FI951341L (fi) | Bentseenialkanoiinihapot sydän-verisuonisairauksia varten | |
| ID17424A (id) | Penghambat matriks metaloproteasa oleh senyawa-senyawa fenetil tersubstitusi | |
| ZA974032B (en) | Substituted oxobutyric acids as matrix metalloproteinases inhibitors. | |
| DE69401967D1 (de) | Abspaltbare Hydroxycarbonsäuren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |